CPSC recall 21729
Evrysdi™ (risdiplam)
- CPSC
- unknown
- Published 2021-03-18
On 2021-03-18 the CPSC announced a recall of Evrysdi™ (risdiplam) by Genentech A Member, citing the bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug expo….
| Agency | CPSC |
|---|---|
| Recall number | 21729 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2021-03-18 |
| Published | 2021-03-18 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Genentech A Member |
| Distribution | US |
Product
Evrysdi™ (risdiplam) | This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Reason
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.